ADVERTISEMENTs
.png)
Neha Vapiwala named president-elect of radiation oncology society
Vapiwala is a nationally recognized expert in treating patients with prostate and other genitourinary cancers.
Neha Vapiwala / Image- Penn Medicine
The American Society for Radiation Oncology (ASTRO), the largest radiation oncology society in the world, has elected Dr. Neha Vapiwala as its president-elect. She will represent ASTRO's 10,000 members, including physicians, physicists, biologists, dosimetrists, radiation therapists, nurses, and other professionals involved in radiation oncology care.
Vapiwala will take office on Oct.1 at the ASTRO’s 66th Annual Meeting in Washington, DC, and then serve as president for a year beginning in fall 2025, followed by a year each as chair and immediate past chair of the Board of Directors.
The Eli Glatstein Professor in Radiation Oncology in the Perelman School of Medicine at the University of Pennsylvania, Vapiwala has help various leadership roles at the university and serves as dean of admissions for the Perelman School of Medicine.
From 2019 to 2023, she served on the ASTRO board of directors as secretary/treasurer and chaired the ASTRO Finance/Audit Committee, maintaining the society’s financial health during the pandemic. She played a pivotal role in advancing initiatives related to radiation oncology workforce analysis, trainee resource expansion, and early career member engagement.
"Serving ASTRO in this role is a tremendous honor, responsibility, and opportunity for me to listen to and learn from our members. By engaging voices throughout the radiation oncology community and cultivating new and existing partnerships, I will strive to generate deeper understanding of and appreciation for our field, within and beyond ASTRO,” said Vapiwala.
Key policy issues for Vapiwala include strengthening support for scientific research and innovation, expanding patient access to radiation therapy, and promoting a supportive environment for all radiation oncology professionals.
“I aim to foster a successful, united future for our specialty by engaging with our diverse membership, gathering stakeholder perspectives, and encouraging conversations on a broad range of issues impacting our field and how we care for our patients,” she said.
Vapiwala is a nationally recognized expert in treating patients with prostate and other genitourinary cancers. She is a member of the National Cancer Institute’s Prostate Cancer Task Force and the JAMA Oncology editorial board. Additionally, she serves on committees involving prostate cancer detection and treatment with the National Comprehensive Cancer Network and the National Clinical Trials Network and is the principal investigator of multiple clinical trials.
Vapiwala has chaired multiple committees fostering partnerships between radiation, medical, and surgical oncologists and recently completed a term as chair of the Accreditation Council of Graduate Medical Education’s Residency Review Committee for Radiation Oncology.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpg)
.jpg)
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login